title: NAFLD: obeticholic acid for the treatment of fatty liver disease--NASH no more?
authors.forename: Katrina
authors.initials: K
authors.lastname: Ray
mesh_terms: D002635:Chenodeoxycholic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects; D000099150:Receptor, Farnesoid X-Activated
chemical_list: D002635:Chenodeoxycholic Acid; D005765:Gastrointestinal Agents; D018160:Receptors, Cytoplasmic and Nuclear; D000099150:Receptor, Farnesoid X-Activated; C464660:obeticholic acid